IQVIA HOLDINGS INC. Accounts Payable and Other Accrued Liabilities, Current
IQVIA HOLDINGS INC. (IQV) had Accounts Payable and Other Accrued Liabilities, Current of $3.64 billion as of 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Notes › Payables and Accruals
us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent · last filed 2026-05-05
- 2026-03-31: Accounts Payable and Other Accrued Liabilities, Current $3.64B.
- 2025-12-31: Accounts Payable and Other Accrued Liabilities, Current $3.75B.
- 2025-09-30: Accounts Payable and Other Accrued Liabilities, Current $3.55B.
- 2025-06-30: Accounts Payable and Other Accrued Liabilities, Current $3.40B.
| Period end | Accounts Payable and Other Accrued Liabilities, Current |
|---|---|
| 2026-03-31 | $3.64B 10-Q · filed 2026-05-05 |
| 2025-12-31 | $3.75B 10-Q · filed 2026-05-05 |
| 2025-09-30 | $3.55B 10-Q · filed 2025-10-28 |
| 2025-06-30 | $3.40B 10-Q · filed 2025-07-22 |
| 2025-03-31 | $3.56B 10-Q · filed 2025-05-06 |
| 2024-12-31 | $3.68B 10-K · filed 2026-02-17 |
| 2024-09-30 | $3.43B 10-Q · filed 2024-10-31 |
| 2024-06-30 | $3.31B 10-Q · filed 2024-07-22 |
| 2024-03-31 | $3.46B 10-Q · filed 2024-05-02 |
| 2023-12-31 | $3.56B 10-K · filed 2025-02-13 |
| 2023-09-30 | $3.13B 10-Q · filed 2023-11-01 |
| 2023-06-30 | $3.01B 10-Q · filed 2023-08-01 |
| 2023-03-31 | $3.14B 10-Q · filed 2023-04-28 |
| 2022-12-31 | $3.32B 10-K · filed 2024-02-15 |
| 2022-09-30 | $2.97B 10-Q · filed 2022-10-27 |
| 2022-06-30 | $2.85B 10-Q · filed 2022-07-22 |
| 2022-03-31 | $2.82B 10-Q · filed 2022-04-28 |
| 2021-12-31 | $2.98B 10-K · filed 2023-02-15 |
| 2021-09-30 | $2.66B 10-Q · filed 2021-10-22 |
| 2021-06-30 | $2.76B 10-Q · filed 2021-07-28 |
| 2021-03-31 | $2.82B 10-Q · filed 2021-04-23 |
| 2020-12-31 | $2.81B 10-K · filed 2022-02-16 |
| 2020-09-30 | $2.46B 10-Q · filed 2020-10-22 |
| 2020-06-30 | $2.29B 10-Q · filed 2020-07-23 |
| 2020-03-31 | $2.38B 10-Q · filed 2020-04-30 |
| 2019-12-31 | $2.51B 10-K · filed 2021-02-12 |
| 2019-09-30 | $2.19B 10-Q · filed 2019-11-01 |
| 2019-06-30 | $2.14B 10-Q · filed 2019-07-24 |
| 2019-03-31 | $2.12B 10-Q · filed 2019-05-02 |
| 2018-12-31 | $2.29B 10-K · filed 2020-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |